PACS Group (NYSE:PACS) Coverage Initiated by Analysts at Macquarie

Macquarie started coverage on shares of PACS Group (NYSE:PACSFree Report) in a research report released on Friday, Marketbeat reports. The firm issued an outperform rating and a $35.00 target price on the stock.

PACS has been the subject of several other reports. Stephens reaffirmed an overweight rating and issued a $31.00 target price on shares of PACS Group in a research report on Tuesday, May 14th. Citigroup began coverage on PACS Group in a research report on Monday, May 6th. They set a buy rating and a $32.00 price objective for the company. Truist Financial reissued a buy rating and set a $32.00 price objective on shares of PACS Group in a research report on Wednesday, May 15th. Oppenheimer boosted their price objective on PACS Group from $31.00 to $32.00 and gave the stock an outperform rating in a research report on Wednesday, May 15th. Finally, Royal Bank of Canada boosted their price objective on PACS Group from $30.00 to $32.00 and gave the stock an outperform rating in a research report on Wednesday, May 15th. Seven research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, PACS Group has an average rating of Buy and a consensus target price of $31.57.

Check Out Our Latest Report on PACS Group

PACS Group Stock Down 2.1 %

NYSE PACS opened at $29.57 on Friday. The company has a debt-to-equity ratio of 5.75, a current ratio of 1.56 and a quick ratio of 1.56. The firm has a 50-day moving average price of $27.84. PACS Group has a 1-year low of $22.61 and a 1-year high of $31.76.

PACS Group (NYSE:PACSGet Free Report) last released its earnings results on Monday, May 13th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.30 by $0.08. The firm had revenue of $934.72 million during the quarter, compared to analyst estimates of $893.07 million. On average, sell-side analysts forecast that PACS Group will post 1.51 EPS for the current year.

Insider Activity at PACS Group

In related news, CEO Jason Hulse Murray sold 1,607,142 shares of the company’s stock in a transaction that occurred on Monday, April 15th. The stock was sold at an average price of $21.00, for a total value of $33,749,982.00. Following the completion of the transaction, the chief executive officer now directly owns 62,754,551 shares of the company’s stock, valued at $1,317,845,571. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

About PACS Group

(Get Free Report)

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Featured Stories

Analyst Recommendations for PACS Group (NYSE:PACS)

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.